Concise Review: Erythroid Versus Myeloid Lineage Commitment: Regulating the Master Regulators
Linda Wolff, Rita Humeniuk · Stem Cells · 2013
Developmental processes, like blood formation, are orchestrated by transcriptional networks. Those transcriptional networks are highly responsive to various environmental stimuli and affect common precursors resulting in increased production of cells of the erythroid lineage or myeloid lineage (granulocytes, neutrophils, and macrophages). A significant body of knowledge has accumulated describing transcription factors that drive differentiation of these two major cellular pathways, in particular the antagonistic master regulators such as GATA-1 and PU.1. However, little is known about factors that work upstream of master regulators to enhance differentiation toward one lineage. These functions become especially important under various stress conditions like sudden loss of red blood cells or pathogen infection. This review describes recent studies that begin to provide evidence for such factors. An increased understanding of factors regulating cellular commitment will advance our understanding of the etiology of diseases like anemia, cancer, and possibly other blood related disorders.
Cited by 41 works. doi:10.1002/stem.1379
Authors
References
- Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
- Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1
- The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
- Requirement of Transcription Factor PU.1 in the Development of Multiple Hematopoietic Lineages
- Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.
- Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.
- Multilineage gene expression precedes commitment in the hemopoietic system.
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential